Belmont, CA (PRWEB) April 29, 2015: Xicepta Sciences, Inc., a biotech company in Belmont, CA, launches a molecular medical food, Agitan X, for Parkinson’s disease that produces 80% improvement on all symptoms based on the company's case study involving a Parkinson's disease patient. Agitan X contains embryonic peptides from vaccine-grade chicken egg extract with microRNA nucleotides and peptides that replenishes what the disease has depleted in the sufferer’s body. It also contains other natural ingredients including Amino Acids and Dopamine properties.
The core research and biotechnology of the embryonic peptide was developed by Dr. Gheorghe Mihaescu, an international expert in the fields of Experimental Immunology in Oncology, Steroid Biochemistry, Radio-assay Methodologies, and Geriatric Nutrition. Dr. Mihaescu has authored 32 published scientific papers in the aforementioned fields and has also performed human clinical studies on the benefits of the embryonic peptides. He also holds 15 invention patents, which have been recognized and prized by the European scientific community at the prestigious Brussels and Geneva Conventions.
The effectiveness of Agitan X in alleviating the disease’s symptoms can be attributed to the neuroregenerative function of the factors and the miRNA strands that can be found in the embryonic peptides. These factors cross easily and intact from digestion in the large intestine to the blood stream where they interact and contribute to the renewal of the neural cell life cycle. The rest of the products’ natural ingredients are designed to enhance the effectiveness of Agitan X.
Read more: http://www.prweb.com/releases/2015/04/prweb12681294.htm